This 43-year-old woman presented with a 2-month history of progressive facial erythema, edema, and induration. The medical history was remarkable for goides, for which she had been treated with, PUVA and interferon.
SNOWBIRD, UTAH -- Transformation of mycosis fungoides to large cell lymphoma occurs in about 30% of patients with stage IIB-IV disease. Such patients have a poor prognosis, Dr. Scott R. Florell said at a seminar on clinical dermatology sponsored by Westwood-Squibb.
A biopsy from the woman's face showed periadnexal infiltrates of large lymphoid cells that were CD3 positive and CD7 and CD30 negative T-cell gene rearrangement studies confirmed a monoclonal population and showed an identical band pattern to that seen with her initial diagnosis of mycosis fungoides, said Dr. Florell, a dermatologist at the University of Utah, Salt Lake City.
The patient was treated with CHOP chemo therapy (cyclophosphamide, doxorubicin, vincristine, prednisone), and she had a dramatic initial response.
Several weeks later, however, she again presented with facial erythema, edema and induration, as well as lymphadenopathy and organomegaly. The white blood cell count was 70,000 per [micro]L and the lactic dehydrogenase level was 12 000 U/L.
Despite the aggressive, chemotherapy regimen the woman developed pulmonary infiltrates and died about 4 months after transformation of her mycosis fungoides to large cell lymphoma.
|Printer friendly Cite/link Email Feedback|
|Publication:||Family Practice News|
|Article Type:||Brief Article|
|Date:||Mar 1, 2001|
|Previous Article:||Gauge Asthma Severity Before Trying to Treat the Disease.|
|Next Article:||Precancerous Skin Lesions Are Showing Up in Younger Patients.|